Healius Ltd

ASX:HLS

Australia / Salud / Proveedores y servicios sanitarios

Visión general

Noticias

Finanzas históricas a 10 años

Precio

1,39 AUD


Key Metrics	Latest
Total Revenue	1,788 B
Adjusted EBITDA	94,8 M
EBITDA Margin	5,3%
Net Profit Margin	0,3%
Total Assets	3,067 B
Total Debt	1,399 B

10Y Historical Financial Statements

Summary Financials


Summary Financials

	Fiscal Year Ending										Latest
(in millions)	Jun-15	Jun-16	Jun-17	Jun-18	Jun-19	Jun-20	Jun-21	Jun-22	Jun-23	Jun-24	12 Months

Revenue	1,580	1,642	1,659	1,705	1,566	1,570	1,914	2,289	1,707	1,746	1,788
% Growth		3.9%	1.0%	2.8%	-8.1%	0.2%	21.9%	19.6%	-25.4%	2.3%

Adjusted EBITDA	365	307	239	138	168	144	311	530	140	106	95
% Margin	23.1%	18.7%	14.4%	8.1%	10.7%	9.1%	16.3%	23.1%	8.2%	6.1%	5.3%

Adjusted EBIT	229	167	117	81	108	86	271	484	98	65	65
% Margin	14.5%	10.2%	7.1%	4.7%	6.9%	5.5%	14.1%	21.2%	5.7%	3.8%	3.6%

Adjusted Net Income	243	114	(83)	16	55	(92)	61	323	(47)	(169)	5
% Margin	15.4%	6.9%	-5.0%	0.9%	3.5%	-5.9%	3.2%	14.1%	-2.8%	-9.7%	0.3%

Adjusted Basic EPS	0.48	0.22	(0.16)	0.03	0.09	(0.15)	0.10	0.55	(0.08)	(0.26)	0.01

Cálculos de apoyo

Income Statement

Balance Sheet

Statement of Cashflows


Income Statement
											Original
AUD	Fiscal Year Ending										Latest
(in millions)	Jun-15	Jun-16	Jun-17	Jun-18	Jun-19	Jun-20	Jun-21	Jun-22	Jun-23	Jun-24	Dec-24
	FY - 9	FY - 8	FY - 7	FY - 6	FY - 5	FY - 4	FY - 3	FY - 2	FY - 1	FY	LTM

Revenue	1,580	1,642	1,659	1,705	1,566	1,570	1,914	2,289	1,707	1,746	1,788
% Growth	NA	3.9%	1.0%	2.8%	-8.1%	0.2%	21.9%	19.6%	-25.4%	2.3%

Cost of Revenue	(868)	(939)	(995)	(1,138)	(1,041)	(1,058)	(1,181)	(1,300)	(1,153)	(1,205)	(1,241)
Gross Profit	711	703	663	566	525	512	733	989	554	541	547
% Revenue	45.0%	42.8%	40.0%	33.2%	33.5%	32.6%	38.3%	43.2%	32.5%	31.0%	30.6%

Research and Development	0	0	0	0	0	0	0	0	0	0	0
Selling and Marketing	0	0	0	0	0	0	0	0	0	0	0
General and Admin	(183)	(209)	(238)	(244)	(225)	(82)	(86)	(110)	(76)	(81)	(83)
Other Inc / (Exp)	(456)	(380)	(896)	(258)	(193)	(315)	(423)	(415)	(814)	(1,039)	(438)
Total Operating Exp	(639)	(588)	(1,133)	(502)	(418)	(396)	(509)	(525)	(889)	(1,121)	(520)

Operating Income	73	114	(470)	65	108	116	224	464	(335)	(579)	27
% Revenue	4.6%	7.0%	-28.3%	3.8%	6.9%	7.4%	11.7%	20.3%	-19.6%	-33.2%	1.5%

Interest Expense	(67)	(58)	(43)	(35)	(26)	(53)	(56)	(49)	(62)	(71)	(73)
Pre-tax Income	6	56	(513)	30	82	63	168	415	(397)	(650)	(46)
Earnings of Discontinued Ops.	11	37	0	0	(2)	(154)	(23)	16	12	(10)	9
Provision for Taxes	111	(18)	(4)	(25)	(25)	21	(102)	(122)	17	14	14
Net Income to Company	128	75	(517)	4	55	(71)	44	308	(368)	(646)	(23)
% Margin	8.1%	4.5%	-31.2%	0.2%	3.5%	-4.5%	2.3%	13.5%	-21.5%	-37.0%	-1.3%

Minority Interest in Earnings	0	0	0	0	0	0	0	0	0	0	0
Net Income to Stockholders	128	75	(517)	4	55	(71)	44	308	(368)	(646)	(23)

Preferred Dividends	0	0	0	0	0	0	0	0	0	0	0
Other Adj.	(11)	(37)	0	0	2	154	23	(16)	(12)	10	(9)

Net Income to Common	117	38	(517)	4	57	83	66	292	(380)	(636)	(32)
% Margin	7.4%	2.3%	-31.2%	0.2%	3.7%	5.3%	3.5%	12.8%	-22.3%	-36.4%	-1.8%

As Reported
Basic EPS (Continuing Ops)	0.23	0.07	(0.99)	0.01	0.09	0.13	0.11	0.50	(0.67)	(0.96)	0.06
Diluted EPS (Continuing Ops)	0.23	0.07	(0.99)	0.01	0.09	0.13	0.11	0.49	(0.67)	(0.96)	0.06

WA Basic Shares Out.	511.41	520.22	521.43	521.63	606.91	622.74	618.82	583.54	569.76	659.76	776.67
WA Diluted Shares Out.	511.41	520.22	521.46	521.97	607.40	623.01	626.53	591.91	569.76	659.76	776.67

EBITDA, EBIT Reconciliation
EBT, Incl. Unusual Items	6	56	(513)	30	82	63	168	415	(397)	(650)	(46)
Addback: Net Interest Expense	67	58	43	35	26	53	56	49	62	71	73
Addback: Other Non Operating Expenses, Total	0	0	0	0	0	0	23	0	0	0	0
Addback: Depreciation & Amortization	135	140	122	57	60	58	41	45	42	41	30
Addback: Restructuring Charges	0	0	0	0	0	0	0	21	36	34	31
Addback: Merger / Acquisition Expenses	0	0	0	0	0	0	0	0	9	8	7
Addback: Goodwill Impairment	0	0	469	0	0	0	0	0	350	603	0
Addback: Gain (Loss) On Sale Of Invest.	0	0	0	0	0	0	0	0	0	0	0
Addback: Gain (Loss) On Sale Of Assets	0	0	0	0	0	0	0	0	0	0	0
Addback: Asset Writedown	26	66	119	16	0	0	0	0	39	0	0
Addback: In Process R&D Expenses	0	0	0	0	0	0	0	0	0	0	0
Addback: Insurance Settlements	0	0	0	0	0	0	0	0	0	0	0
Addback: Legal Settlements	0	0	0	0	0	(24)	24	0	0	0	0
Addback: Other Unusual Items	131	(14)	0	0	0	(6)	0	0	0	0	0
Adjusted EBITDA	365	307	239	138	168	144	311	530	140	106	95
% Margin	23.1%	18.7%	14.4%	8.1%	10.7%	9.1%	16.3%	23.1%	8.2%	6.1%	5.3%

Adjusted EBIT	229	167	117	81	108	86	271	484	98	65	65
% Margin	14.5%	10.2%	7.1%	4.7%	6.9%	5.5%	14.1%	21.2%	5.7%	3.8%	3.6%

Adjusted Net Income Reconciliation
Net Income to Company	128	75	(517)	4	55	(71)	44	308	(368)	(646)	(23)
Addback: Unusual Items	157	53	587	16	0	(30)	24	21	433	645	38
Less: Tax Benefit of Unusual Items (26%)	(41)	(14)	(153)	(4)	0	8	(6)	(5)	(113)	(168)	(10)
Adjusted Net Income	243	114	(83)	16	55	(92)	61	323	(47)	(169)	5
% Margin	15.4%	6.9%	-5.0%	0.9%	3.5%	-5.9%	3.2%	14.1%	-2.8%	-9.7%	0.3%

Error de carga

Healius Ltd

ASX:HLS

Australia / Salud / Proveedores y servicios sanitarios

Finanzas históricas a 10 años